rucaparib in recurrent ovarian cancer: ariel3 trial
Published 6 years ago • 212 plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
6:12
rucaparib for recurrent ovarian cancer
-
9:31
ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
-
4:25
rucaparib: clinical activity in relapsed ovarian cancer
-
5:04
rucaparib and ariel3 – positive results from the phase 3 trial in ovarian cancer patients
-
4:20
rucaparib explored for high-risk ovarian cancer
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
2:58
rucaparib for relapsed ovarian cancer: safety profile
-
5:02
recurrent ovarian cancer: quadra trial
-
2:09
rucaparib maintenance for recurrent ovarian carcinoma
-
2:07
rucaparib in platinum-sensitive ovarian cancer
-
1:42
phase iii results for rucaparib in ovarian cancer
-
1:41
the clinical activity of rucaparib in patients with ovarian cancer
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer
-
1:20
dr. ledermann on rationale for ariel3 trial in ovarian cancer
-
3:07
rucaparib maintenance and monotherapy for ovarian cancer: trial updates
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer